Research progress on early identification and prevention of immunotherapy-related cardiac toxicity in lung cancer patients
10.3760/cma.j.cn115682-20230921-01179
- VernacularTitle:肺癌患者免疫治疗相关心脏毒性早期识别及预防的研究进展
- Author:
Qiuyue LI
1
;
Yanjun ZHOU
;
Xiaolin WANG
;
Yule HU
;
Yan WANG
;
Tao LIANG
Author Information
1. 中国医学科学院北京协和医学院护理学院，北京 100144
- Keywords:
Review;
Lung neoplasms;
Immunotherapy;
Cardiotoxicity;
Nursing
- From:
Chinese Journal of Modern Nursing
2024;30(8):1116-1120
- CountryChina
- Language:Chinese
-
Abstract:
With the widespread application of immunotherapy, the overall survival rate of lung cancer patients continues to improve, and the accompanying immune-related adverse events are increasingly valued, with cardiac toxicity being the most severe. Early identification and prevention of immunotherapy-related cardiac toxicity in lung cancer patients significantly improves their quality of life. This paper summarizes the early identification (risk factors, evaluation tools, and prediction models) and preventive measures of immunotherapy-related cardiac toxicity in lung cancer patients so as to provide a reference for the early identification, prevention, and management of immunotherapy-related cardiac toxicity in lung cancer patients.
